| abstract |
A compound of formula (I) or a pharmaceutically acceptable derivative thereof is disclosed, wherein the variables are as defined in the specification. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3 mammalian protein kinase. Pharmaceutically acceptable compositions comprising these compounds and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders are also described. |